Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the design of serotonin and dopamine modulators, making it valuable in research for antidepressants, antipsychotics, and cognitive enhancers. The trifluoromethoxy group enhances metabolic stability and membrane permeability, improving drug bioavailability. Commonly employed in medicinal chemistry for lead optimization in neuropharmacology.